InVivo Therapeutics to Present at Lazard Capital Markets Annual Healthcare Conference
CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--InVivo Therapeutics (OTCBB: NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that Frank Reynolds, CEO of InVivo, will be presenting at the Lazard Capital Markets Annual Healthcare Conference on Tuesday, November 16, 2010 at 3:40 P.M. Eastern Time at the St. Regis Hotel in New York City.
A live webcast of this presentation will be available on the investor relations page of the InVivo Therapeutics website at [ www.invivotherapeutics.com ]. A replay of the webcast will be archived on the website for two weeks.
About InVivo Therapeutics
InVivo Therapeutics Holdings Corp. is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company was founded in 2005 on the basis of proprietary technology co-invented by Robert Langer, ScD, Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, MD, who is affiliated with Massachusetts General Hospital in Boston.